Equities analysts expect that Procter & Gamble Co (NYSE:PG) will post $17.49 billion in sales for the current quarter, Zacks reports. Six analysts have made estimates for Procter & Gamble’s earnings. The highest sales estimate is $17.73 billion and the lowest is $17.22 billion. Procter & Gamble reported sales of $16.69 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 4.8%. The firm is expected to issue its next earnings report on Friday, October 18th.
According to Zacks, analysts expect that Procter & Gamble will report full year sales of $70.36 billion for the current year, with estimates ranging from $69.72 billion to $70.91 billion. For the next fiscal year, analysts expect that the company will post sales of $72.74 billion, with estimates ranging from $71.56 billion to $73.20 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Procter & Gamble.
Procter & Gamble (NYSE:PG) last issued its earnings results on Tuesday, July 30th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.04. Procter & Gamble had a return on equity of 22.92% and a net margin of 5.76%. The company had revenue of $17.09 billion for the quarter, compared to analyst estimates of $16.86 billion. During the same period in the prior year, the firm earned $0.94 earnings per share. Procter & Gamble’s revenue for the quarter was up 3.6% on a year-over-year basis.
PG has been the topic of a number of research reports. Deutsche Bank upped their target price on Procter & Gamble from $106.00 to $109.00 and gave the stock a “hold” rating in a research report on Monday, June 17th. Scotiabank reaffirmed a “buy” rating on shares of Procter & Gamble in a research report on Friday, July 5th. SunTrust Banks upped their target price on Procter & Gamble to $120.00 and gave the stock a “hold” rating in a research report on Wednesday. DZ Bank reaffirmed a “sell” rating on shares of Procter & Gamble in a research report on Wednesday, April 24th. Finally, Wells Fargo & Co reaffirmed a “buy” rating and set a $135.00 target price (up from $125.00) on shares of Procter & Gamble in a research report on Tuesday. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and twelve have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $108.15.
In other news, insider Carolyn M. Tastad sold 25,645 shares of the firm’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $106.08, for a total transaction of $2,720,421.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Steven D. Bishop sold 30,000 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $105.38, for a total value of $3,161,400.00. Following the sale, the insider now directly owns 75,031 shares of the company’s stock, valued at $7,906,766.78. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 247,335 shares of company stock valued at $26,476,375. Insiders own 1.84% of the company’s stock.
Institutional investors have recently made changes to their positions in the company. Camarda Financial Advisors LLC grew its stake in shares of Procter & Gamble by 59.2% during the 2nd quarter. Camarda Financial Advisors LLC now owns 269 shares of the company’s stock worth $29,000 after acquiring an additional 100 shares during the period. SeaBridge Investment Advisors LLC bought a new position in shares of Procter & Gamble during the 4th quarter worth $36,000. Smart Portfolios LLC grew its stake in shares of Procter & Gamble by 48.0% during the 4th quarter. Smart Portfolios LLC now owns 450 shares of the company’s stock worth $41,000 after acquiring an additional 146 shares during the period. Financial Management Professionals Inc. grew its stake in shares of Procter & Gamble by 71.5% during the 2nd quarter. Financial Management Professionals Inc. now owns 463 shares of the company’s stock worth $51,000 after acquiring an additional 193 shares during the period. Finally, Advocacy Wealth Management Services LLC boosted its stake in Procter & Gamble by 301.3% in the 2nd quarter. Advocacy Wealth Management Services LLC now owns 602 shares of the company’s stock worth $66,000 after purchasing an additional 452 shares during the period. 62.17% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE:PG traded down $0.29 during trading on Friday, reaching $116.44. 12,265,590 shares of the stock were exchanged, compared to its average volume of 7,368,813. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.60 and a current ratio of 0.75. Procter & Gamble has a 1-year low of $78.49 and a 1-year high of $121.76. The stock has a fifty day moving average price of $113.31. The stock has a market capitalization of $296.08 billion, a price-to-earnings ratio of 25.76, a price-to-earnings-growth ratio of 3.54 and a beta of 0.45.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $0.7459 per share. This represents a $2.98 annualized dividend and a dividend yield of 2.56%. The ex-dividend date of this dividend is Thursday, July 18th. Procter & Gamble’s dividend payout ratio is presently 65.93%.
About Procter & Gamble
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.
See Also: Outstanding Shares and The Effect on Share Price
Get a free copy of the Zacks research report on Procter & Gamble (PG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.